A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER-Reference-Cited by-同舟云学术

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER

Published:2020-10-26 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Goldman Jonathan W.,Mazieres Julien,Barlesi Fabrice,Dragnev Konstantin H.,Koczywas Marianna,Göskel Tuncay,Cortot Alexis B.,Girard Nicolas,Wesseler Claas,Bischoff Helge,Nadal Ernest,Park Keunchil,Lu Shun,Taus Alvaro,Cobo Manuel,Estrem Shawn T.,Wijayawardana Sameera R.,Turner Kellie,Oakley Gerard Joseph,Hurt Karla C.,Chiang Alan Y.,Hossain Anwar M.,John William J.,Paz-Ares Luis

Funder

Eli Lilly and Company

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference34 articles.

1. K-ras mutation subtypes in NSCLC and associated co-occuring mutations in other oncogenic pathways;Scheffler;J Thorac Oncol,2019

2. KRAS mutations in lung cancer;Karachaliou;Clin Lung Cancer,2013

3. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs;Kris;JAMA,2014

4. Prognostic and predictive value in KRAS in non-small-cell lung cancer. a review;Wood;JAMA Oncol,2016

5. Treatment paradigms for advanced stage non-small cell lung cancer in the era of multiple lines of therapy;Stinchcombe;J Thorac Oncol,2009

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising Combinatorial Therapeutic Strategies against Non-Small Cell Lung Cancer;Cancers;2024-06-12

2. Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments;Drugs;2024-04-16

3. Emerging Therapies in Kirsten Rat Sarcoma Virus (+) Non-Small-Cell Lung Cancer;Cancers;2024-04-09

4. Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets;Therapeutic Advances in Medical Oncology;2024-01

5. Clinical Trial and Real-World Outcomes of Patients With Metastatic NSCLC in the Post-Platinum–Based Chemotherapy Failure Setting;JTO Clinical and Research Reports;2023-11